Dino Mehic/LinkedIn
Dec 14, 2025, 13:14
Dino Mehic with Colleagues: BDUC – What is It and What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn:
“Bleeding Disorder of Unknown Cause (BDUC): What Do We Know?
- We are excited to share that we recently summarized nearly two decades of clinical and research experience in the management of patients with bleeding disorders of unknown cause (BDUC).
- This review represents a long-standing, collaborative effort to better understand the natural history of BDUC led by Ingrid Pabinger, Johanna Gebhart, and Cihan Ay at our institution (Medical University of Vienna).
- At the American Society of Hematology 2025 Annual Meeting in Orlando, Prof. Pabinger presented our current understanding of how to predict and treat BDUC-an important step toward improving care for this under-recognized patient population.
Title: Predictors for future bleeding in bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Cihan Ay, Johanna Gebhart, Ingrid Pabinger

Link to the publication in ASH Hematology”
Stay informed with ASH2025 updates on Hemostasis Today.
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV